New in vitro model of inclusion body myositis based on human iPSC-myotubes

New in vitro model of inclusion body myositis based on human iPSC-myotubes

Neurology/psychiatric

Inclusion body myositis (IBM) is an inflammatory myopathy causing proximal and distal muscle weakness. IBM’s cause remains unknown, lacking validated models, biomarkers and effective treatment strategies. Histopathological…

Article Source
https://www.bioworld.com/articles/718319-new-in-vitro-model-of-inclusion-body-myositis-based-on-human-ipsc-myotubes

More From Author

Intel unveils Xe Super Sampling 2 technologies for enhanced gaming – Investing.com

3 Key Things for Nvidia Stock Investors to Watch as GTC 2025 Kicks Off Today

3 Key Things for Nvidia Stock Investors to Watch as GTC 2025 Kicks Off Today

Listen to the Podcast Overview

Watch the Keynote